Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00615069 · ClinicalTrials.gov registry record · Phase 2
Study of the Large Diameter GORE EXCLUDER® AAA Endoprosthesis in Abdominal Aneurysms
A Phase 2 study, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT00615069 is a Phase 2 study that has completed, run by W.L.Gore & Associates. The registered enrollment target is 35 participants.
The verdict
NCT00615069, a Phase 2 study, has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy of the 31 mm GORE EXCLUDER® AAA Endoprosthesis in the treatment of infrarenal abdominal aortic aneurysms
Interventions
- DEVICE 31 mm GORE EXCLUDER® AAA Endoprosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2006-05 |
| Est. Completion | 2014-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00615069
The ClinicalTrials.gov registry entry for NCT00615069 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 31 mm GORE EXCLUDER® AAA Endoprosthesis is the first listed.
NCT00615069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00615069 about?
NCT00615069 is a clinical study titled "Study of the Large Diameter GORE EXCLUDER® AAA Endoprosthesis in Abdominal Aneurysms". The purpose of this study is to assess the safety and efficacy of the 31 mm GORE EXCLUDER® AAA Endoprosthesis in the treatment of infrarenal abdominal aortic aneurysms
What is the current status of trial NCT00615069?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2006-05. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00615069?
The interventions under investigation include: 31 mm GORE EXCLUDER® AAA Endoprosthesis (DEVICE).
Who is sponsoring clinical trial NCT00615069?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.